GREGORY FIX: Open Payments
NPI 1649554791 · GENEVA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 35 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $197 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| ALK-Abello, Inc | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $40 |
| Novo Nordisk Inc | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
Products named: ELIQUIS, AIRSUPRA, VOQUEZNA, GLASSIA, NURTEC ODT, FARXIGA, NEFFY, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
